本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

武田製藥

14.90
+0.03000.20%
盤後14.900.00000.00%16:41 EDT
成交量:137.50萬
成交額:2,052.24萬
市值:455.79億
市盈率:36.00
高:15.02
開:15.00
低:14.88
收:14.87
資料載入中...
2022/01/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/14

超過5%披露

TAKEDA PHARMACEUTICAL CO LTD
2021/09/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals